Gieni R S, Yang X, Kelso A, Hayglass K T
Department of Immunology, University of Manitoba, Winnipeg, Canada.
Immunology. 1996 Jan;87(1):119-26.
Polarized expression of T-helper type-1 (Th1)- or Th2-like patterns of cytokine production frequently correlates with disease outcome. Previously, we have described the long-lived reciprocal regulation of ovalbumin (OVA)-specific IgE (> 95% inhibition) and IgG2a (300-800-fold increased) production following administration of high MW OVA polymers (OVA-POL), in both de novo and ongoing OVA (alum)-induced responses. Here, limiting dilution analysis (LDA) was used to compare precursor frequencies of CD4 T cells producing interferon-gamma (IFN-gamma), interleukin-4 (IL-4) or IL-10 following OVA versus OVA-POL exposure in vivo. Adjuvants were not used, so as to circumvent their impact on measurement of precursor frequencies. We found that the two forms of antigen elicited T-cell activation of comparable intensity, as indicated by equivalent precursor frequencies of clonogenic antigen-specific CD4 T cells. However, they elicited qualitatively different cytokine responses. OVA-POL treatment led to 10-fold higher (mean of six independent LDA experiments) frequencies of IFN-gamma-producing cells, and a mean fivefold lower frequency of IL-10-producing cells, than was observed following in vivo administration of unmodified OVA. Thus, the high MW polymerized form of antigen acted to steer commitment of naive (for this antigen) CD4 T-cell activation from a situation in which IL-10 producers outnumbered IFN-gamma-producing cells by a factor of 4:1 (found in mice administered OVA), to one where IFN-gamma producers dominated by a factor of 11:1 (in mice given OVA-POL), i.e. a qualitative shift in the nature of the OVA-specific response induced from Th2-like to Th1-like. In vivo co-administration of anti-IFN-gamma monoclonal antibody (mAb) abolished the capacity of OVA-POL to preferentially elicit Th1-like dominance. Interestingly, although the ratios of IFN-gamma:IL-4 and IFN-gamma:IL-10 OVA-specific precursor frequencies were strongly increased following OVA-POL exposure (mean 18- and 47-fold higher), the frequency of IL-4-producing CD4 T cells did not differ significantly. The data suggest that this modified antigen promotes in vivo commitment of naive T cells towards a Th1-like response, with consequent inhibition of IgE and enhancement of IgG2a responses, not through direct effects on IL-4 production, but via decreased frequencies of IL-10 and increased frequencies of IFN-gamma-producing OVA-specific CD4 cells. Collectively, the data (1) demonstrate the ability to manipulate commitment of antigen-driven CD4 T-cell populations in naive mice to specific patterns of cytokine gene expression, and (2) provide in vivo evidence of the regulatory role played by IFN-gamma in limiting induction and/or expansion of IL-4- and IL-10-producing CD4 cells to protein allergens.
1型辅助性T细胞(Th1)或类似Th2型细胞因子产生模式的极化表达通常与疾病结果相关。此前,我们已经描述了在从头开始和持续的卵清蛋白(OVA)(明矾)诱导的反应中,给予高分子量OVA聚合物(OVA-POL)后,OVA特异性IgE(>95%抑制)和IgG2a(增加300-800倍)产生的长期相互调节。在这里,使用有限稀释分析(LDA)来比较体内OVA与OVA-POL暴露后产生干扰素-γ(IFN-γ)、白细胞介素-4(IL-4)或IL-10的CD4 T细胞的前体频率。未使用佐剂,以避免其对前体频率测量的影响。我们发现,两种形式的抗原引发的T细胞激活强度相当,克隆形成性抗原特异性CD4 T细胞的等效前体频率表明了这一点。然而,它们引发了质的不同的细胞因子反应。与体内给予未修饰的OVA相比,OVA-POL处理导致产生IFN-γ的细胞频率高10倍(六个独立LDA实验的平均值),产生IL-10的细胞频率平均低五倍。因此,高分子量聚合形式的抗原促使幼稚(针对该抗原)CD4 T细胞激活的方向发生转变,从IL-10产生细胞比产生IFN-γ的细胞多4倍的情况(在给予OVA的小鼠中发现),转变为产生IFN-γ的细胞以11:1的比例占主导的情况(在给予OVA-POL的小鼠中),即从类似Th2型诱导的OVA特异性反应性质向类似Th1型的质的转变。体内共同给予抗IFN-γ单克隆抗体(mAb)消除了OVA-POL优先引发类似Th1型优势的能力。有趣的是,尽管OVA-POL暴露后IFN-γ:IL-4和IFN-γ:IL-10的OVA特异性前体频率之比大幅增加(平均分别高18倍和47倍),但产生IL-4的CD4 T细胞频率没有显著差异。数据表明,这种修饰的抗原促进幼稚T细胞在体内向类似Th1型反应的方向发展,从而抑制IgE并增强IgG2a反应,不是通过对IL-4产生的直接影响,而是通过降低IL-10的频率和增加产生IFN-γ的OVA特异性CD4细胞的频率。总体而言,这些数据(1)证明了在幼稚小鼠中操纵抗原驱动的CD4 T细胞群体向特定细胞因子基因表达模式发展的能力,(2)提供了体内证据,证明IFN-γ在限制蛋白质过敏原诱导和/或扩增产生IL-4和IL-10的CD4细胞方面发挥的调节作用。